Breaking Down Barriers to ADHD Treatment: A Game-Changer for Canberra Residents
Accessing ADHD medication just got a whole lot easier for Canberra residents. In a move that’s set to transform the way ADHD care is delivered, appropriately trained general practitioners (GPs) in Canberra can now prescribe ADHD medications without requiring repeated specialist reviews. This means eligible patients—those stable on their medication, aged six or older, and with an existing specialist diagnosis—can bypass the often lengthy and cumbersome process of frequent psychiatrist, paediatrician, or neurologist visits. But here’s where it gets even more impactful: GPs won’t need approval from the Chief Health Officer to continue prescribing, streamlining the process further.
Health Minister Rachel Stephen-Smith highlighted the dual benefits of this change, stating, “Families and individuals living with ADHD often face hurdles in accessing treatment. These reforms are the first step in our commitment to enhancing ADHD care in the ACT.” By reducing delays, easing the demand for specialist referrals, and cutting unnecessary administrative red tape, the changes aim to make treatment more accessible and efficient.
And this is the part most people miss: while GPs gain more autonomy, specialists like psychiatrists, paediatricians, and neurologists will now need approval from the Chief Health Officer to prescribe ADHD medications within specific dosage ranges. This balance ensures patient safety while expanding access. Is this the right approach, or does it place too much responsibility on GPs? We’d love to hear your thoughts in the comments.
Dr. Kerrie Aust, president of the Australian Medical Association (AMA) ACT, praised the move as a “sensible reform” that aligns with clinical realities and patient needs. “It maintains safeguards while recognizing GPs as central care providers,” she said. “We’re eager to see the positive impact this will have on Canberrans who’ve long sought a more responsive system.”
For GPs who prefer not to expand their ADHD practice, a shared-care model with specialists remains an option. This flexibility ensures that patients still receive coordinated care, even if their GP isn’t fully onboard with the new prescribing responsibilities.
ADHD affects an estimated 6–10% of Australian children and young people, and 2–10% of adults, making these changes particularly significant. Dr. Rebekah Hoffman, chair of the Royal Australian College of GPs (RACGP) NSW&ACT, emphasized the importance of this step in improving timely access to treatment. “These updates will make a real difference for families facing long waits for specialist appointments,” she said. “Trained GPs can now provide consistent, accessible care within a clear clinical framework.”
This reform was an election promise, and more changes are on the horizon. Later this year, GPs with additional training will be able to diagnose ADHD and initiate medication, further expanding their role. “These changes will ease pressure on the health system while ensuring safe, monitored prescribing,” Ms. Stephen-Smith explained.
Dr. Hoffman previously noted that recognizing GPs’ role in ADHD management was “overdue”. “GPs are well-equipped to handle ADHD, just as we manage other chronic conditions. Our holistic approach positions us perfectly to support these patients,” she said. With successful models already in place, such as in Queensland, this shift feels like a natural progression.
But here’s the controversial question: Are GPs truly prepared to take on this expanded role, or should ADHD care remain primarily in the hands of specialists? Let us know your stance in the comments.
For more information, visit the ACT Government’s ADHD care page here or explore HealthDirect’s resources here. The conversation is just beginning—what’s your take on this transformative change?
